Bipolar depression can look very similar to major depression. A person may seek care because they feel exhausted, hopeless, withdrawn, or unable to function, while earlier periods of unusually high energy, reduced need for sleep, impulsivity, or irritability receive less attention.
When that broader mood history is not recognized, treatment may begin with an antidepressant alone. Antidepressants are not automatically harmful for every person with bipolar disorder, but they require greater caution than they do in unipolar depression. Used without an appropriate mood-stabilizing treatment, they can contribute to mania, hypomania, rapid cycling, or further mood instability in some patients.
At Thrive Center for Health in Grand Rapids, we do not assume that every difficult-to-treat depressive episode is the same. We take time to understand the full course of a patient’s symptoms before discussing medication changes or ketamine therapy.
Why Bipolar Depression Can Be Difficult to Recognize
Bipolar disorder involves episodes of depression together with periods of mania or hypomania. The type, duration, and severity of these episodes help clinicians distinguish among bipolar I disorder, bipolar II disorder, and related conditions.
Bipolar I disorder is defined by at least one manic episode. Mania can involve a significant change in mood, energy, activity, judgment, and behavior. Symptoms may become severe enough to disrupt daily functioning, require hospitalization, or include psychosis.
Bipolar II disorder involves major depressive episodes and hypomanic episodes. Hypomania is less severe than mania, but it still represents a noticeable change from a person’s usual mood and behavior. Because hypomania may feel productive, energetic, or simply “better than depressed,” patients may not identify it as a symptom when describing their history.
This is one reason bipolar II disorder can be missed. A person may seek treatment during depression while the periods that would change the diagnosis remain unreported or unrecognized.
Our overview of what bipolar disorder is provides additional background on these mood patterns and how they may affect daily life.
Why We Look Beyond the Current Depressive Episode
A diagnosis should not be based only on how someone feels during a single appointment. We want to understand the pattern that has developed over time.
During an evaluation, we may ask about:
- Periods of needing much less sleep without feeling tired
- Unusually elevated, expansive, or irritable moods
- Racing thoughts or rapid speech
- Increased activity, confidence, or goal-directed behavior
- Impulsive spending, sexual behavior, substance use, or risk-taking
- Previous reactions to antidepressants
- Family history of bipolar disorder
- Changes noticed by partners, relatives, or close friends
These details matter because bipolar depression and unipolar depression are treated differently. A history of activation, agitation, insomnia, or an unusually elevated mood after starting an antidepressant does not prove that someone has bipolar disorder, but it deserves careful clinical attention.
Our approach to bipolar disorder treatment in Michigan begins with understanding this full clinical picture rather than matching one symptom to one treatment.
Why Antidepressants Require Careful Use in Bipolar Disorder
Antidepressants can be helpful for some people with bipolar depression, particularly when they are used selectively alongside an appropriate mood-stabilizing medication. However, their role is more limited and more controversial than it is in major depressive disorder.
Current clinical guidelines advise against antidepressant monotherapy for bipolar I depression. Without a mood stabilizer or another appropriate bipolar treatment, an antidepressant may increase the risk of switching into mania or hypomania. Some patients may also experience more frequent mood episodes or mixed symptoms, such as depression combined with agitation, racing thoughts, or reduced sleep.
The risk is not identical for every patient or every antidepressant. Research has produced mixed findings, and some people use adjunctive antidepressants without experiencing a mood switch. That complexity is precisely why medication decisions should be individualized.
We do not tell patients that all antidepressants are bad or that a difficult past experience means medication cannot help. Instead, we review which medications were used, how they were combined, how long they were taken, what changed, and whether the response suggests that the treatment plan or diagnosis needs to be reconsidered.
Patients should never stop an antidepressant, mood stabilizer, or other psychiatric medication abruptly without guidance from their prescribing provider.
What Treatment for Bipolar Depression Usually Prioritizes
Treatment commonly centers on mood stabilizers, certain atypical antipsychotic medications, psychotherapy, and ongoing monitoring. The appropriate plan depends on whether the patient is currently depressed, manic, hypomanic, mixed, or relatively stable.
Medication selection also depends on previous responses, side effects, medical history, pregnancy considerations, sleep, substance use, co-occurring conditions, and the need to prevent future episodes—not only relieve the current one.
Psychotherapy can also play an important role. Approaches may focus on recognizing early warning signs, creating stable sleep and daily routines, managing stress, strengthening relationships, and improving adherence to a long-term treatment plan.
At Thrive, our psychiatric medication management service includes evaluation, prescribing, monitoring, and medication adjustments for bipolar disorder and other mental health conditions. Some patients come to us primarily for medication management. Others use it alongside care from an established therapist or another provider.
When Bipolar Depression Remains Difficult to Treat
Some people continue to experience significant depression despite multiple appropriately selected treatments. Others cannot tolerate the medications they have tried or improve only partially.
At this point, we reassess before recommending another intervention. Persistent symptoms can reflect several different situations:
- The diagnosis may need clarification.
- The current medication may not have been used at an adequate dose or duration.
- Side effects may be limiting adherence.
- Sleep disruption, substance use, trauma, anxiety, or another condition may be affecting recovery.
- The patient may be experiencing mixed features rather than a purely depressive episode.
- A different treatment pathway may be appropriate.
This kind of reassessment is part of the specialized mental health care we provide in Grand Rapids. Our goal is not simply to add another treatment. We want to understand why previous care has not provided enough relief.
Understanding how bipolar disorder affects the brain can also help patients and families make sense of why treatment sometimes needs to be reconsidered. Our post on how bipolar disorder affects the brain covers the neuroscience behind mood cycling and treatment response.
What the Research Says About IV Ketamine for Bipolar Depression
Ketamine interacts with NMDA receptors and influences glutamate signaling, giving it a different mechanism from conventional antidepressants.
Small randomized trials have studied intravenous ketamine as an add-on treatment for people with treatment-resistant bipolar depression who were already taking a mood stabilizer. These studies observed short-term improvements in depressive symptoms following a single infusion.
The findings are promising, but the limitations are important. The early trials included small numbers of participants, studied ketamine as an adjunct rather than a replacement for mood-stabilizing treatment, and followed patients for relatively short periods. Later evidence reviews have continued to identify uncertainty about long-term effectiveness, maintenance strategies, and the risk of mood switching.
The available studies do not establish that ketamine has a universally safer mood-switch profile than antidepressants. Manic or hypomanic symptoms appear to have been uncommon in the small trials, but the evidence is not large or mature enough to eliminate that concern.
IV ketamine for bipolar depression is an off-label use. It has not been approved specifically for this condition, individual results vary, and treatment is not appropriate for every patient.
For a broader look at how ketamine acts on the brain, see our overview of how ketamine works in the brain.
How We Evaluate Ketamine Candidacy
We do not recommend ketamine based on a diagnosis alone.
Before treatment, we review the patient’s psychiatric history, current symptoms, previous manic or hypomanic episodes, medication regimen, medical conditions, substance-use history, and response to earlier treatments. Active or inadequately controlled mania, psychosis, and certain medical or medication concerns may affect whether treatment is appropriate or when it can begin.
Our medical screening process for ketamine therapy includes separate psychiatric and medical evaluations. These steps help us assess safety, clarify candidacy, and establish a baseline for monitoring symptoms.
For patients with bipolar disorder, we also pay close attention to mood stability. A reduction in depression is not the only outcome that matters. We need to monitor for changes in sleep, energy, impulsivity, irritability, activity, and judgment that could signal emerging hypomania or mania.
When IV ketamine is appropriate, we explain what the treatment involves, what is known about the evidence, and what remains uncertain. Patients can also learn what to expect during a first ketamine infusion before deciding whether to proceed.
We Support Coordination With Existing Providers
Starting care at Thrive does not automatically mean leaving your psychiatrist, therapist, or primary care provider.
With your permission, we can coordinate with members of your existing care team when that communication supports a safer and more consistent plan. This may be particularly important when a provider outside our clinic prescribes a mood stabilizer or monitors another part of your mental or physical health.
Our role is not to disrupt care that is already helping. We provide specialized evaluation, psychiatric medication management, and ketamine treatment when clinically appropriate while supporting continuity wherever possible.
Reducing the Stigma Around an Accurate Diagnosis
Some patients feel frightened or discouraged when bipolar disorder is first discussed. They may worry about what the diagnosis means, how others will view them, or whether they will always feel controlled by unpredictable moods.
We want to be direct: bipolar disorder is a serious condition, but an accurate diagnosis is not a judgment or a life sentence. It gives patients and clinicians a clearer framework for choosing treatment, recognizing warning signs, and avoiding interventions that may increase instability.
A diagnosis should explain the pattern of symptoms and help guide care. It should never be used to dismiss a patient’s concerns or reduce the person to a label.
Frequently Asked Questions
Do antidepressants always make bipolar disorder worse?
No. Some people with bipolar depression may use an antidepressant as part of a carefully managed treatment plan.
The primary concern is antidepressant monotherapy, particularly in bipolar I disorder. Antidepressants may trigger mania, hypomania, rapid cycling, or mixed symptoms in some patients, but the level of risk varies. Decisions should consider the type of bipolar disorder, current mood state, previous medication response, and other treatments being used.
What signs might suggest that depression is part of bipolar disorder?
Possible signs include past periods of unusually high or irritable mood, reduced need for sleep, racing thoughts, impulsivity, increased activity, or a history of becoming activated after starting an antidepressant.
These experiences do not confirm a diagnosis on their own. A qualified mental health professional must evaluate the timing, duration, severity, and overall pattern of symptoms.
What role can IV ketamine have in bipolar depression?
IV ketamine may be considered for some patients with difficult-to-treat bipolar depression after a thorough psychiatric and medical evaluation.
Small studies have found short-term antidepressant effects when ketamine was added to an existing mood stabilizer. The evidence remains limited, long-term outcomes are less certain, and ketamine for bipolar depression is an off-label use.
Can ketamine be combined with a mood stabilizer?
The early controlled studies of ketamine for bipolar depression used it as an add-on to mood-stabilizing treatment. However, compatibility cannot be assumed for every medication or patient.
We review all prescriptions, dosages, supplements, and medical conditions during screening. Any medication adjustments must be made in coordination with the appropriate prescribing provider.
Does Thrive provide medication management for bipolar disorder?
Yes. We provide psychiatric medication management for bipolar disorder, including evaluation, medication review, ongoing monitoring, and adjustments when clinically appropriate.
Patients may use medication management as their primary service or alongside ketamine therapy and care from outside providers.
What should I do if I think I am becoming manic?
Contact your mental health provider promptly, particularly if you notice a major reduction in sleep, rapidly increasing energy, impulsive behavior, agitation, racing thoughts, or changes in judgment.
If symptoms create an immediate danger to you or someone else, call 911 or go to the nearest emergency department. If you are experiencing suicidal thoughts or emotional crisis, call or text 988 for the Suicide & Crisis Lifeline.
Key Takeaways
- Bipolar depression can resemble major depression, especially when previous hypomanic or manic symptoms are not recognized.
- Antidepressants are not universally harmful, but antidepressant monotherapy can destabilize mood in some people with bipolar disorder.
- Current guidelines recommend mood-stabilizing treatment rather than antidepressant monotherapy for bipolar I depression.
- A complete mood history is essential before changing a diagnosis or treatment plan.
- Small studies suggest that IV ketamine may reduce symptoms of treatment-resistant bipolar depression in the short term, but the evidence remains limited.
- IV ketamine for bipolar depression is an off-label use and should follow thorough psychiatric and medical screening.
- No psychiatric medication should be stopped or changed without guidance from the prescribing provider.
A More Accurate Understanding Can Change the Path Forward
When depression has not responded to several treatments—or when an antidepressant has led to agitation, insomnia, impulsivity, or an unusually elevated mood—the next step should be a careful reassessment rather than another assumption.
At Thrive Center for Health, we take time to understand the full arc of your mood history. Depending on what we learn, the appropriate next step may involve psychiatric medication management, coordination with your existing providers, IV ketamine therapy, or another treatment pathway.
We will not promise that one intervention will solve a complex mood disorder. We will listen, explain the options honestly, and help you consider a plan grounded in your diagnosis, safety, treatment history, and goals.
When you are ready to discuss what comes next, you can contact our Grand Rapids team.
About Thrive Center for Health
At Thrive Center for Health in Grand Rapids, Michigan, we care for patients with complex mental health and chronic pain conditions, including people who have not found adequate relief through standard treatment.
We provide ketamine therapy, psychiatric medication management, and complementary patient support in a compassionate, approachable, and affirming environment. Our process emphasizes thorough evaluation, individualized care, continuous clinical monitoring, and honest communication from the first consultation through each stage of treatment.
Our clinic is located at 847 Parchment Drive SE, Suite 105, Grand Rapids, MI 49546.
Medical Disclaimer
This content is provided for educational purposes only and does not constitute medical advice, diagnosis, or an individualized treatment recommendation. IV ketamine for bipolar depression is an off-label use and may not be appropriate for every patient. Individual results vary, and no outcome can be guaranteed. Always consult a qualified healthcare provider before starting, stopping, or changing a psychiatric medication or treatment.
Works Cited
Diazgranados, N., Ibrahim, L., Brutsche, N. E., et al. (2010). A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Archives of General Psychiatry, 67(8), 793–802.
Keramatian, K., Chithra, N. K., & Yatham, L. N. (2023). The CANMAT and ISBD guidelines for the treatment of bipolar disorder: Summary and a 2023 update of evidence. Focus, 21(4), 344–353.
National Institute of Mental Health. (2025). Bipolar disorder. National Institutes of Health.
Rodolico, A., Cutrufelli, P., Di Francesco, A., et al. (2024). Efficacy and safety of ketamine and esketamine for unipolar and bipolar depression: An overview of systematic reviews with meta-analysis. Frontiers in Psychiatry, 15, 1325399.
Yildiz, A., Siafis, S., Mavridis, D., Vieta, E., & Leucht, S. (2023). Comparative efficacy and tolerability of pharmacological interventions for acute bipolar depression in adults: A systematic review and network meta-analysis. The Lancet Psychiatry, 10(9), 693–705.
Zarate, C. A., Jr., Brutsche, N. E., Ibrahim, L., et al. (2012). Replication of ketamine’s antidepressant efficacy in bipolar depression: A randomized controlled add-on trial. Biological Psychiatry, 71(11), 939–946.